Other anti-inflammatory activities were also reported from a new compound, 57, and a known compound, 62. These two compounds showed inhibitory activity towards Tumor Necrosis Factor α (TNF-α)-induced nuclear factor kappa B (NF-κB) activation (a therapeutical target in cancer), with IC50 values of 35.23 and 22.52 μmol/mL, respectively [31]. This evidence concerns the gene TNF and cancer.